Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen
Details for Australian Patent Application No. 2001227771 (hide)
International Classifications
Event Publications
6 February 2003 Application Open to Public Inspection
Published as AU-B-2001227771
30 November 2006 Change of Name(s) of Applicant(s), Section 104
U.S. Army Medical Research & Material Command The name of the applicant has been changed to The United States of America as represented by the Secretary of the Army, Walter Reed Army Institute of Research (WRAIR) 2002
31 May 2007 Application Accepted
Published as AU-B-2001227771
27 September 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser